Cargando…

Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial

OBJECTIVE: An educational, interactive journal [Vision and Memory Stimulating (VMS) journal] was developed to boost patient confidence and promote long-term adherence with weekly vision self-monitoring in age-related macular degeneration (AMD) patients at risk for vision loss from new-onset neovascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bittner, Ava K, Torr-Brown, Sheryl, Arnold, Ellen, Nwankwo, Antonia, Beaton, Patricia, Rampat, Radhika, Dagnelie, Gislin, Roser, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004088/ https://www.ncbi.nlm.nih.gov/pubmed/24791222 http://dx.doi.org/10.4172/2155-9570.1000320

Ejemplares similares

Vision protection therapy for prevention of neovascular age-related macular degeneration
por: Luttrull, Jeffrey K., et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision
por: Frenkel, Ronald E P, et al.
Publicado: (2016)

Self-Reported Visual Ability Versus Task Performance in Individuals With Ultra-Low Vision
por: Kartha, Arathy, et al.
Publicado: (2023)

Development of the Ultra-Low Vision Visual Functioning Questionnaire (ULV-VFQ)
por: Jeter, Pamela E., et al.
Publicado: (2017)

Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure
por: Yıldırım, Şeyda, et al.
Publicado: (2018)

Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]
por: Bahrami, Hossein, et al.
Publicado: (2006)

Measuring visual information gathering in individuals with ultra low vision using virtual reality
por: Kartha, Arathy, et al.
Publicado: (2023)

Development of The Chinese Version of Ultra-Low Vision Visual Functioning Questionnaire-150
por: Cong, Jing, et al.
Publicado: (2023)

Living with Ultra-Low Vision: An Inventory of Self-Reported Visually Guided Activities by Individuals with Profound Visual Impairment
por: Adeyemo, Olukemi, et al.
Publicado: (2017)

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2019)

The effects of loading ranibizumab on vision-related quality of life in the treatment of low-risk neovascular age-related macular degeneration
por: Daldal, Hatice
Publicado: (2022)

Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis
por: Sadda, SriniVas, et al.
Publicado: (2022)

Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration
por: Cheng, Anny M, et al.
Publicado: (2023)

The Effect of a Head-mounted Low Vision Device on Visual Function
por: Wittich, Walter, et al.
Publicado: (2018)

Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce
por: Ayton, Lauren N., et al.
Publicado: (2020)

Detection of Nonexudative Macular Neovascularization on Structural OCT Images Using Vision Transformers
por: Kihara, Yuka, et al.
Publicado: (2022)

Low-vision intervention in individuals with age-related macular degeneration
por: Gopalakrishnan, Sarika, et al.
Publicado: (2020)

Intraocular vision-improving devices in age-related macular degeneration
por: Grzybowski, Andrzej, et al.
Publicado: (2020)

Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration
por: Almeida, David R P, et al.
Publicado: (2021)

Choroidal Neovascularization and Haller Vessel Morphology Associated with Vision and Treatment Number after 1 Year in Age-related Macular Degeneration
por: Kim, Seungmin, et al.
Publicado: (2021)

Ashtanga-Based Yoga Therapy Increases the Sensory Contribution to Postural Stability in Visually-Impaired Persons at Risk for Falls as Measured by the Wii Balance Board: A Pilot Randomized Controlled Trial
por: Jeter, Pamela E., et al.
Publicado: (2015)

Improvements in Test–Retest Variability of Static Automated Perimetry by Censoring Results With Low Sensitivity in Retinitis Pigmentosa
por: Bittner, Ava K., et al.
Publicado: (2020)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
por: Khanani, Arshad M, et al.
Publicado: (2019)

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age‐related macular degeneration in daily clinical practice: data from the FRB! registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2022)

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
por: Singerman, L J, et al.
Publicado: (2008)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Lateral gain is impaired in macular degeneration and can be targeted to restore vision in mice
por: Rizzi, M., et al.
Publicado: (2022)

Two-Photon Vision in Age-Related Macular Degeneration: A Translational Study
por: Łabuz, Grzegorz, et al.
Publicado: (2022)

Alterations of color vision and pupillary light responses in age-related macular degeneration
por: Decleva, Diego, et al.
Publicado: (2023)

Efficacy of low-vision devices in elderly population with age-related macular degeneration
por: Singh, Kirti, et al.
Publicado: (2023)

IDA VMS help guide
por: Burnett, T
Publicado: (1990)

ALPHI VMS help guide
por: Burnett, T
Publicado: (1990)

Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2021)

Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration
por: Deemer, Ashley D., et al.
Publicado: (2017)

Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration
por: Pondorfer, Susanne G., et al.
Publicado: (2019)

Vision-Related Quality of Life and Seasonal Affective Disorder in Patients with Glaucoma and Macular Degeneration
por: Szulborski, Kira J., et al.
Publicado: (2022)

Implantable vision-enhancing devices and postoperative rehabilitation in advanced age-related macular degeneration
por: Borkenstein, Andreas F., et al.
Publicado: (2022)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Macular Pigment and Its Contribution to Vision
por: Loskutova, Ekaterina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g8bsvn6g6aunhq7hhpot9inaqh